George Perry is Dean of the College of Sciences and Professor of Biology at The University of Texas at San Antonio. Perry is recognized in the field of Alzheimers disease research particularly for his work on oxidative stress. Perry received his bachelors of arts degree in zoology with high honors from University of California, Santa Barbara. After graduation, he headed to Scripps Institution of Oceanography and obtained his Ph.D. in marine biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures. In 1982, Perry joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment. He is distinguished as one of the top Alzheimer’s disease researchers with over 900 publications, one of the top 100 most-cited scientists in neuroscience and behavior and one of the top 25 scientists in free radical research. Perry has been cited over 40,000 times and is recognized as an ISI highly cited researcher. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimers Disease. He is a fellow of the American Association for the Advancement of Sciences and past-president of the American Association of Neuropathologists. He received the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native American Scientists. Most recently he has been named a Foreign Correspondent Member of the Spanish Royal Academy of Sciences. Perrys research is primarily focused on how Alzheimer disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals. Throughout his career, Perry has collaborated with Mexican universities and researchers. He was instrumental in the signing of a Memorandum of Understanding between UTSA and National Autonomous University of Mexico, Center for Research and Advanced Studies of the National Polytechnic Institute,University of Texas, and University of Vericruzana. He has served as an external reviewer for Mexican universities and as a mentor for undergraduate and graduate students from Mexico, publishing papers with several of these students. Since 1984 he has been invited to speak at numerous scientific meetings, conferences, and workshops held in Mexico.

Dr. Perry research are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. He is currently working to determine the sequence of events leading to damage caused by and the source of metabolic abnormalities. Their current studies focus on (i) the mechanism for RNA-based redox metal binding; (ii) the consequences of RNA oxidation on protein synthesis rate and fidelity; (iii) the role of redox active metals in mediating prooxidant and antioxidant properties; (iv) the signal transduction pathways altered in Alzheimer disease that allow neurons to evade apoptosis; and (v) mechanism of phosphorylation control of oxidative damage to neurofilament proteins.

Dr. Christi Magrath received Ph.D at Tulane University in 1999. Currently she is a Associate Professor at the Troy University, USA.

Molecular biology
Yeast genetics
Transcription and replication of nucleic acids

Dr. Gang Zhang got his Ph. D. from Shandong Normal University and Chinese Academy of Sciences, China, majoring on the study of mouse pronuclear exchange and nuclear transfer in 2005. Then, he worked as a Postdoc Fellow at the Department of Cell and Systems Biology (2005-2007), and then moved to the Centre for Research in Neurodegenerative Diseases as a Research Technician II (2008-2012), University of Toronto, Canada. During this period, his research mainly focused on Parkinson disease, which included the differentiation of neural stem cells into dopamine neurons, and the molecular mechanism of Parkinson disease. Particularly, he developed a new method, designated as “Combinatorial Strategy” to clone different plasmid vectors with various clone sites, and also optimized the protocols of lentiviral transduction to establish stable transgene cell lines efficiently. Now, he is a Research Associate at Massachusetts General Hospital, Harvard Medical School, Harvard University.

Gene Engineering, Transgene & Pathology: Lentiviral vector construction, production, titration, transduction, protein function analysis, various molecular cloning and PCR, site-directed mutagenesis, Western blotting, mechanism of Parkinson Disease, etc. Cellular & Developmental Biology: Neural stem cell isolation, proliferation, differentiation, various tissue culture, immunostaining, brain tumor stem cell renewal and differentiation, establishment of transgene cell lines, etc. Reproduction Biology and Embryology: Mouse cloning, in vitro fertilization, in vivo and in vitro development of embryos, oocytes maturation, etc.

Peter Duesberg, is a Professor of Molecular and Cell Biology at the University of California, Berkeley. He moved to Berkeley, California, in 1964 to work at the University of California, Berkeley, following completion of a Ph.D. in chemistry at the University of Frankfurt, Germany. He isolated the first cancer gene through his work on retroviruses in 1970, and mapped the genetic structure of these viruses. In 1968-1970 he demonstrated that influenza virus has a segmented genome. He was also the recipient of a seven-year Outstanding Investigator Grant from the National Institute of Health.

 

Carcinogenesis, Biochemistry, Biophysics, Structural Biology

Nancy B. Schwartz received a B.S. in Chemistry and a Ph.D. in Biochemistry from the University of Pittsburgh and is currently Professor, Departments of Pediatrics and Biochemistry and Molecular Biology at the University of Chicago. She has served on several NIH study sections, foundation review boards, and editorial boards. She is director of the Kennedy Research Center, NIH M.D./Ph.D. GDTP, HHMI Med-into-Grad, and NIH PREP. She has had continuous R01 research funding, received both a MERIT award and a Mentor of Excellence from NIH, and is Director of a P01 and a P30 Intellectual and Developmental Disabilities Center. Her current research focuses on the role of glycoconjugates in the developing limb and brain using a combination of molecular, genetic and biochemical approaches. Ongoing projects include identifying mutations responsible for the chondrodystrophic conditions in several model systems; elucidating the underlying pathophysiology of the matrix deficiencies: developing novel genetic models to study proteoglycan function during skeletal development; creating models to study cortical development in altered micro environments; and elucidating the role of proteoglycans as biomodulations of growth factor signaling.

1. Chondrogenesis

2. Gliogenesis

3. Proteoglycans

4. Glycosyltransferase

Dr. Perez-Polo JR received Ph.D at Stanford University in 1970. Currently he is a I. H. Kempner Professor and Chair & Professor at the University of Texas, USA.

Our long-term goals are to understand the inflammatory mechanisms triggered by trauma in the central nervous system. We are interested in the effects of chronic inflammation on genotoxic and epigenetic outcomes, cell death, impaired blood brain barrier and immunological activation in CNS and resultant developmental and adult outcomes. We have developed interventions ranging from endogenous receptor antagonists and gene specific “decoy” inhibition of transcription factor binding to gene promoter sites as potential therapies. We also study the role of trauma-induced post-translational modifications that regulate intracellular trafficking in stress response mechanisms. Our hypothesis is that oxidative stress in the nervous system, caused by chronic or acute trauma, triggers inflammatory responses that result in the uncoupling of gene networks responsible for the resultant deficits. Our studies focus on: the Bcl-protein family and inflammatory cytokines. We rely on in vitro and in vivo rodent models for perinatal ischemia, spinal cord and head injury.

Dr. Boyd received a B.S in Physiology from the University of Illinois, Urbana-Champaign and an M.S. in Biology from the University of Memphis. He then received his Ph.D in Molecular Biology from the University of Texas at Austin in 1986. Dr. Boyd carried out postdoctoral studies at the University of California, San Diego and the Salk Institute before moving to The Ohio State University College of Medicine as Assistant Professor of Pharmacology in 1990. Dr Boyd is currently Associate Professor of Neuroscience in the Department of Neuroscience. Dr. Boyd is a reviewer for numerous journals and has served on multiple NIH study sections. He has been active in graduate education, recently completing a four-year term as Associate Director of the Integrated Biomedical Science Graduate Program (IBGP).

Research activities in Dr Boyds laboratory have emphasized a molecular biological analysis of neuronal nicotinic acetylcholine receptors (nAChRs). Neuronal nAChRs mediate synaptic transmission in many parts of the vertebrate central nervous system, in autonomic ganglia, retina, and adrenal medulla. We have studied transcriptional regulation of nAChR subunit genes as well the identifying a new allosteric site on the a4b2 neuronal nAChR. This site is being explored for its potential as a binding site for new drugs which modulate nAChR activity and could be used to aid smoking cessation. We have also cloned the zebrafish neuronal nAChR genes and determined the expression pattern of zebrafish neuronal nAChR genes during development. The information derived from these studies is being used to develop zebrafish as a model for studying the role of nAChRs in normal development of the nervous system and the mechanisms by which nicotine perturbs vertebrate nervous system development

Dr Michael McAlear received his Bachelors Degree in Biochemistry from McGill University in 1986, and Ph.D. in Experimental Medicine from the McGill Cancer Center in 1992. Dr Michael McAlear pursued his post-doctoral studies on the genetics of the cell cycle in budding yeast with Dr. C. Holm at the Harvard University Biolabs, and then at the University of California, San Diego. In 1995 he started as an Assistant Professor in the Molecular Biology and Biochemistry Department at Wesleyan University, was promoted to Associate Professor in 2002, and he has been the Chairman of the Molecular Biology and Biochemistry Department since 2010.  His research programs have included studies in budding yeast on DNA replication, DNA repair, and more recently ribosome and rRNA biogenesis, and transcriptional regulation.

Biochemistry, Biophysics, Molecular Biology.

Dr. Yunfu Lin has received his PhD in Fudan University during the period of 1990 to 1993. Currently, he is working as an Assistant Professor in Baylor College of Medicine. He has authored more than 30 research articles/books

Genomic instability, DNA recombination and repair, Trinucleotide repeat diseases

Dr. Chunying Li is an Assistant Professor of Biochemistry & Molecular Biology at Wayne State University School of Medicine, and also holds joint appointments at Cardiovascular Research Institute, and Karmanos Cancer Institute at Wayne State University. Dr. Li received his PhD in Physiology in 2005, and did his Postdoctoral training during 2005-2008, both at the University of Tennessee Health Science Center. He was an Assistant Professor of Pediatrics at Le Bonheur Childrens Medical Center, University of Tennessee Health Science Center during 2008-2009. He was a recipient of numerous awards and honors, such as The Leonard Share Young Investigator Award (2004), American Heart Association BGIA award (2007-2010), and Pardee Foundation Research Award (2011-2012). Dr. Li has published highly-referred manuscripts in top-tier journals such as Cell, Nature, J Exp Med, PNAS. His research interest lies in the organization and regulation of macromolecular signaling complexes in cystic fibrosis, inflammation, and cancer biology.

PDZ-mediated macromolecular complexes in health and diseases; CFTR macromolecular signaling complex in cystic fibrosis and secretory diarrhea; CXCR2 macromolecular signaling complex in vascular diseases, inflammation, and cancer biology; Spatiotemporal dynamics and regulation of macromolecular signaling complex in live cells and animals.

Dr. Pandey received his Ph.D. from Lucknow University, Lucknow, India in 2005 in the area of Biochemistry. He has multidisciplinary research experience and is an author of several papers in the field of Endocrinology, hormones and aging in international top peer reviewed medical journals including Endocrinology, journal of Endocrinology, journal of Nutritional biochemistry and Gastroenterology, Journal of Leukocyte Biology and Enzyme and Microbial Technology.

Molecular biology, Single cell Study, Protein Biochemistry,  Animal handling, Computer Skills.

Kangling Zhang is an associate professor of University of Texas Medical Branch at Galveston. He completed his B.S degree in Chemistry from Anhui University, in 1984, his M.S from University of the Pacific in Biocemistry in 1997 and Ph.D from University of california at San Francisco in Mass Spectrometry in the year 2000. He served as an Assitant Researcher in Mount Sinai University, New york in 1998, senior scientist in ISN pharmaceuticals cOSTA mESA. He is an associate professor in the division of Pharmacology  and also a director of Mass Spectrometry in Loma Linda, CA from 2007.

Histone modifications, DNA methylation/demethylation in epigenetic modulation and regulation of gene expression and their importance in cell differentiation and diseases. Elucidation of epigenetic networks in which protein expression and metabolomic pathways are involved by proteomic and biological approaches

Christopher Edward Mason, is an assistant professor of Computational Genomics at Weill Cornell Medical College. He completed his B.S In Genetics and Biochemistry from University of Wisconsin-Madison and Ph.D in Genome Evolution and postdoctoral in Neuroscience from Yale University. His laboratory work utilizes computational and experimental methodologies to identify and characterize the essential genetic elements that guide the function of the human genome. He perform research in three principal areas: (1) the functional annotation of the human genome by mutational profiling in families with brain malformations and cancer patients, (2) the examination of the elements that orchestrate the development of the human brain and their evolutionary changes, and (3) the development of models for systems and synthetic biology. We use high-throughput methods to generate cell-specific molecular maps of genetic, epigenetic, and transcriptional activity and we use them to create multi-dimensional molecular portraits of development and disease. We develop algorithms to detect, catalog and functionally annotate variants in the genetic pathways that control developmental processes. He has more than 50 publications.

Brain malformations and cancer, Human brain and their evolutionary changes, High-throughput methods

Dr. Yuqing Zhang got her PhD from Shandong University in 2005. Currently she is working in Weill Cornell Medical College. Dr. Zhang research interests include DNA damage/repair and cancer biology and therapy. Dr. Zhang has published more than 20 papers in high impact journals and has presented her work many times nationally and internationally. Dr. Zhang serves on the review panel and editorial board of several journals.

DNA damage/repair, cancer biology, cancer therapy, molecular biology, drug resistance.

Dr. Chaki is doing her postdoctoral research at the Internal Medicine Division of the UT Southwestern Medical Center. Her present research involves deciphering the mechanism of cystic kidney diseases using mouse model of ciliopathies. Dr. Chaki’s previous postdoctoral research at the Pediatric Nephrology Division of the University of Michigan involved identification and characterization of novel genes implicated in Nephronophthisis-related ciliopathies. In 2008, Dr. Chaki obtained her PhD degree in Life Sciences from the Indian Institute of Chemical Biology (IICB-CSIR); CSIR is considered the premier industrial R&D organization in India. Her doctoral thesis was on ‘Molecular Genetic Studies on Oculocutaneous Albinism (OCA) with Special Reference to Tyrosinase-the Causal Gene for OCA type 1’. The broad area of her research is molecular biology, Mendelian disorders, genetics and vision science. Dr. Chaki also holds a Masters and Bachelors degree in Botany from University of Calcutta, India

Molecular Genetics, Mendelian Genetics, Molecular Genomics, Molecular and Cellular Biology, Molecular Medicine

Dr. Madasu, biochemist and molecular biologist, graduated from School of Chemistry, University of Hyderabad, India in 2008. He worked as a postdoctoral fellow (2008-2010) at La Jolla Institute for Allergy and Immunology, USA. Since 2010, Dr. Madasu workings as a research scientist at University of Pennsylvania, Philadelphia, PA, USA. Dr. Madasu is credited with a number of important contributions in protein folding, including cell death, iron-sulfur cluster protein biogenesis, actin nucleation, pathogen infection and structural, functional characterization of proteins. Dr. Madasu is recipient of fellowships from Council of Scientific and Industrial Research, Department of Bitechnology, India and Marie Curie fellowship recipient from European Cell Death Organization. Dr. Madasu also a scientific advisory board member, also member of ASCB, Biophysical Society, and peer reviewer for many national and international journals.

Molecular biology, structural and functional characterization of proteins using various biochemical, biophysical techniques, protein folding, mitochondrial biogenesis, apoptosis, cytoskeleton dynamics and pathogen infection.

Dr. Jeschke completed his medical school and his thesis with summa cum laude. He completed a research Fellowship from 1996-1999 with the University Texas Medical Branch and Shriners Hospital for Children. During this time he completed his Masters of Medical Science. He returned to Germany, to the Department of Surgery at the University of Regensburg where received his surgical training and passed his General Surgery Boards in 2003, but also was awarded the habilitation (PhD) in Experimental Surgery in 2001. Dr. Jeschke returned to the University Texas Medical Branch and Shriners Hospital for Children in 2004 as Faculty, and was made Burn Attending and Coordinator of Research in 2006. He was named Annie Laurie Howard Chair of Burn Surgery in 2008. Dr. Jeschke was appointed Director of the Ross Tilley Burn Centre at Sunnybrook Health Science Centre in 2010. He was also appointed as Surgeon-Scientist in the Division of Plastic and Reconstructive Surgery, Department of Surgery at the University of Toronto. Dr. Jeschke is an Associate Professor of Surgery at the University of Toronto.Dr. Jeschke has been caring for burn patients and conducting research in the field of burns for nearly 20 years and in that time has published more than 214 peer-reviewed articles and has authored several books and chapters on burn care. The quality of his research is reflected by his funding. He was continuously funded as the Principle Investigator since 2000 from the German Research Council, National Institute of Health, Shriners Hospital for Children and Foundations. He was recently awarded a grant from the CFI. As well as his many accomplishments as a researcher, Dr. Jeschke is a highly respected educator. He has mentored and trained more than 45 Ph.D., MD, and other graduate students in the field of burn care and burn-related research. He is a sought after speaker and has lectured around the world. Dr. Jeschke is a member of various organizations, e.g. American Burn Association, Association for Academic Surgery, European Shock Society, Shock Society, International Society of Burn Injuries, Surgical Infection Society, Society for Critical Care Medicine, The American Association for the Surgery of Trauma, and Society University Surgeons. He serves on several boards and committees. He also is a reviewer for the National Institute of Health and Department of Defense. Dr. Jeschke has won numerous awards for teaching and research, including the prestigious Fellow Award of the American Surgical Association Foundation (2006), First Prize Poster Presentation, American Burn Association (2005), Surgery Specialty Award, Society Critical Care Medicine (2004), Von-Langenbeck-Prize from the German College of Surgeons (2004), Prize fort the best scientific work from the German College of Surgeons, Critical Care Chapter (2003), Dr. Werner Fekl Förderprize of the German Society of Critical Care Medicine (2002), Best scientific presentation at the 1st World meeting of the Surgical Infection Society, Madrid, Spain (2002), Wound healing-Prize, German College of Surgeons (2001), Otto-Götze Prize of the Bavarian Society of Surgery (2001), Johann-Nepomuk-von-Nussbaum Prize der Bayerischen Gesellschaft für Chirurgie (2000), and American College of Surgeons Committee on Trauma, Region VI. Winner Residents Award and selected for presentation at the National Competition, Washington DC (1998).

Plastic and Reconstructive Surgery, Immunology

Dr. Sanjib Bhakta is a Senior Lecturer in Microbiology at Birkbeck, University of London. His continued research interestis focussedon developing novel therapeutics to tacklepersistence and drug resistance in Tuberculosis. Following aBSc(Hons), an MSc and a PhD in Molecular Biology & Biochemistry in India, Dr Bhakta joined the Oxford University as an ISIS innovation Senior Research Scholar anda Wellcome Trust International Travelling Fellow. He graduated from The Queen’s College, University of Oxford completing a DPhiland received a “Sir William Paton Prize” for the best research presentation in Pharmacology. He joined Birkbeck as a University Lecturerand became a Fellow of the Higher Education Academy, UK after achieving a post graduate certificate in Teaching and Life Long Learning in Higher Education (PGCHE) from the University of London. He is a core memberof Tuberculosis Drug Discovery-UK, the Institute of Structural and Molecular Biologyand an affiliated Fellow of the Centre for Infection, Immunity and Disease Mechanism. He is an electedFellow of the Royal Society of Medicine and a Chartered Biologist in the UK.

The disease Tuberculosis (TB), once considered eradicated has now become a major global health concern. It is a condition that, if untreated, can last for several years during which patients are debilitated and may disseminate the causal pathogen, Mycobacterium tuberculosis. We characterise the structure, function, regulation and inhibition of key biochemical pathways in mycobacteriato identify and validate potential therapeutic targets in M. tuberculosisas well as to facilitate the development of a new drug treatment against the different physiological stages of M. tuberculosis infection.

Dr. Kao-Ping Chang md, Ph.D. is ana associate professor of Kaohsiung Medical University, Kaohsiung in Taiwan. He is also serving as Chief in Division of Plastic and Reconstructive Surgery, Kaohsiung Medical University. He completed his M.D degree and Ph.D from Kaohsiung Medical University, Kaohsiung, Taiwan and Masters from I-Shou University in Taiwan.  he has been awarded the Best Intern, Kaohsiung Medical University Hospitalin 1993, Best Chief Resident, Department of Surgery, Kaohsiung Medical University Hospital in 1999, Best reconstructive article, annual meeting of Society of Plastic and Reconstructive Surgery, TAIWAN in 2010. He has more than 50 publications.

 

Microsurgery, Head and Neck reconstruction, Breast reconstruction, Composite tissue allotransplantation, Lymphedema, Super-microsurgery, Molecular biology in transplantation immunology

Miguel Angel Medina Torres has received his PhD in University of Malaga during the period of 1989. Currently, he is working as full Professor in University of Malaga

Search for compounds with modulatory effects on angiogenesis. Characterization of the structure/function relationship and turnover mechanisms of L-amino acid decarboxylases in Eukaryotes: Molecular basis and pharmacological implications. Anti-inflammatory strategies. Application of bioinformatics, biophysical and systems biology approaches to the study of polyamine and biogenic amine metabolism and to the systemic study of rare diseases

Mariateresa Volpicella, Ph.D., is a researcher in Molecular Biology at the Faculty of Sciences Biotechnology. She has a degree in Biology and a Ph.D. degree in Biochemistry and Molecular Biology at the University of Bari.  Since 2004 she has worked on teaching lessons for the science-disciplinary BIO/11 (Molecular Biology and Bioinformatics, Laboratory of Molecular Biology and Biotechnology II, Applied Genomics and Bioinformatics) for the three-year degree course in Biotechnology for Innovation in Processes and Products, and the Course Master Degree in Biotechnology for Quality and the Human Food Safety, at the Faculty of Sciences Biotechnologies. She is member of the Board for the Ph.D. Course in “Biochemistry, Molecular Biology and Bioinformatics” at the University of Bari.

Plant molecular biology, Bioremediation

Dr. Gianluca Baldanzi received Ph.D in Molecular Medicine at A.Avogadro University in 2008. Currently he is an Assistant professor  at “A. Avogadro” University & visiting Scientist at Queen Mary University of London.

Function and regulation of SAP gene in T lymphocyte as a regulator of DGK-A. Demonstrating that SAP mediates DGK-A inhibition upon TCR stimulation thus increasing diacylglycerol signaling and T cell responses.
Role of DGK-A in cell transformation promoted by v-Src and NPM-ALK.  In vitro evaluation of DGK-A as a possible pharmaceutical target for the control of tumor cell growth and dissemination.
Activation of DGK-A by HGF and VEGF and molecular determinants of its interaction with Src.
Other interesting fields of research:
Signaling pathways promoting hepatocyte survival such as PI3K, Src and DGK regulation upon adenosine and glicine release in liver preconditioning.
The anti-apoptotic and pro-differenziative proprieties of Ghrelin in myocytes.

Thimios Mitsiadis was born in Greece (Larissa), and he is from 2006 Professor of Oral Biology in the Medical Faculty at the University of Zurich, Switzerland. He conducts research in the fields of stem cells, genetics, molecular and experimental biology related to craniofacial developmental processes. He obtained his DDS degree from the University of Athens (Greece). He got specializations in Restorative Dentistry (1987) and in Pediatric Dentistry (1988) from the University of Lyon (France). There, he also obtained a Master Degree (DEA) in Immunology, Genetics and Differentiation and his PhD Degree in Developmental Biology (1993). He conducted Post-doctoral studies in the University of Helsinki (Finland), Karolinska Nobel Institute (Sweden), and Yale University (USA). From 1996-2002 he was Professor at the University Aix-Marseille (France), Visiting Professor at the Ecole Normale Superieure de Lyon (2003), Clinical Senior Lecturer at King’s College London (2003-2006), and Associate Professor at Dental School of Athens (2004-2005).  

Thimios Mitsiadis conducts research in the fields of stem cells, genetics, molecular and experimental biology, and developmental and evolutionary biology related to craniofacial developmental processes. Prof Mitsiadis is interested in molecules involved in Notch and BMP signalling pathways.

Dr Jenssen earned his PhD at the University of Tromsø, Norway in 2004, did a post doc at CMDR, University of British Columbia, Canada, followed by a research associate position at the same university. In 2009 he joined as a faculty member the Dept. of Science, Systems & Models, at Roskilde University, Denmark. He is serving as a reviewer for 12 peer-reviewed journals, has reviewed international grants for the past two years, serves on several editorial boards and has published close to 50 research articles, review papers and book chapters.

Emerging infectious diseases and the escalating incidence of drug-resistant bacterial strains has fueled the hunt for new anti-infective drug candidates in recent years. A potential new therapeutic approach for treating infectious diseases is the use of cationic host defence peptides, also known as antimicrobial peptides. My research focuses on using sophisticated computer-aided prediction models to aid the development of novel peptide and peptidomimetic molecules that may potentially be used to treat both viral and bacterial pathogens. My work encompasses the generation of both directly antimicrobial peptides and those that do not directly kill the pathogen, but instead fight infection by stimulating the host’s natural innate immune system to promote the clearance of infection.

Dr. He received his Ph.D. degree from the University of Kentucky and conducted his postdoctoral studies in the Department of Biochemistry at University of Wisconsin-Madison. Currently he is a senior principal investigator and associate professor in the Department of Biological Sciences at the National University of Singapore and the Temasek Life Sciences Laboratory.

Dr. He’s research interest encompasses chromatin biology, epigenetics, and plant molecular development. His laboratory currently studies on the chromatin-based or epigenetic regulation of developmental gene expression in plants.

Tomoh is an assistant professor of the Department of Vascular Biology at the Institute of Brain Science, HirosakiUniversity Graduate School of Medicine, Japan.  He received his DDS degree in 1996 from Kyushu dental college and his PhD degree in 2004 from HirosakiUniversity, respectively.  He subsequently joined as a post-doctoral fellow in the laboratory of Dr Stephen Prescott at the Huntsman Cancer Institute, University of Utah.  

His research has been focusing on molecular mechanism of retinoic acid-inducible gene-I (RIG-I)-dependent antiviral signalling

Masood Alam Khan is an Assitant Professor in the college of pharmacy of Al-Qassinm University in Saudi Arabia. He completed his PhD in Biotechnology from Aligarh Muslim University, Aligarh,India. Masood Khan has 30 publications and has been reviewer for many journal that includes Journal of Antimicrobial Chemotherapy, Vaccine, Pharmaceutical Research, European Journal of Clinical Pharmacology, Chemosphere, Cancer, Investigation, Journal of AIDS and HIV Research.

Immune system, Tumors, Autoimmune diseases, Cell signaling pathways

Dr. Calcaterra has published 26 full papers in prestigious journals indexed in PubMed. She has directed three doctoral theses (PhD) at the National University of Rosario. Currently directs other three doctoral theses and three young scientific researchers from CONICET. She is an associate professor since 2000 in the General Biology Area. She teaches cell biology and developmental biology.She has been involved in university management and advisory committees of science and technology.

Dr.Calcaterra is leader of the biochemistry and molecular biology of development at IBR-CONICET. The main goal of Dr. Calcaterra’ lab is to understand the role of single-stranded nucleic acids binding proteins, RNA or DNA, during embryonic development of vertebrates. The animal model used is Danio rerio.

Dr. Mustafa Ozen Completed his PhD from University of Texas, Houstan in 1999 and obtained his MD degree from University University Medical School Kayseri, Turkey in 1992. He is presently working as Professor and Chair, Department of Medical Genetics, Istanbul University Cerrahpasa Medical School Istanbul, Turkey. Dr Mustafa is also an Adjunct Associate Professor in the Department of Pathology, Baylor College of Medicine, Houston, TX.He is associated with the Turkish Council of Scientific and Technological research (TUBITAK) as a member Steering Committee in Health Sciences. He has been awarded the Oncology Research award for the outstanding scientific paper published in 1997, awarded by the Editorial Board of Oncology Research in the year 1998, Presidential Fellowship Award in Recognition of outstanding performance in research, underwritten by the Presidents of the U.T.-Houston Health Science Center (Dr. M. David Low) and the M. D. Anderson Cancer Center (Dr. John Mendelsohn), Houston, TX in 1998. Hehas morethan 50 publications.

Human Genetics, Cancer Research, Molecular Pathology

Prof. Dao Wen Wang has received his PhD in Tongji Medical University during the period of 1992. Currently, he is working as Professor in Huazhong University of Science & Technology.

Molecular Cardiology, translational medicine, molecular biology, cardiovascular internal medicine

Dr. Yu Xue is a professor at the Department of Systems Biology of College of Life Science and Technology of Huazhong University of Science and Technology. He received his B.S. in Polymer Materials and Technology in 2002 and B.E. in Computer Science and Technology in 2003 from the University of Science and Technology of China (USTC). He completed his Ph.D. training in Cell Biology and Bioinformatics in USTC (2002-2006). During the past several years, Dr. Xue has published extensively on computational studies of post-translational modifications (PTMs), including developing novel GPS (Group-based Prediction System) series algorithms, studying several new PTMs (eg., epigenetic modifications), constructing easy-to-use softwares and databases, and proteome-wide analysis of PTMs substrates, etc. His group is currently combining systems biology, bioinformatics, and molecular & cellular biology approaches to study genetic variations that potentially influence protein modification status.

Bioinformatics & Systems Biology, Post-translational modifications of proteins and Protein-protein interaction

Dr Takuro Horii received his Bachelors Degree in Applied Biosciences in 1998, Masters Applied Biosciences in 2000  and Ph.D. Applied Biosciences from Kyoto University, Kyoto, Japan,in 2003.

Epigenetics of embryonic stem cells and germ cells

Dr. Purohit obtained his Bachelor in Pharmacy (B.Pharm) from BRN College of Pharmacy and Master of Technology (M.Tech) in Bioinforamtics from Indian Institute of Information Technology - Allahabad, India. He went on to obtain his doctoral degree in Bioinformatics from the Vellore Institute of Technology, University, Vellore, and followed it with postdoctoral research experience at the University di Torino, Torino, Italy. Presently he is an Assistant Professor (Senior) at Bioinformatics Division, Vellore Institute of Technology, University, Vellore, Tamilnadu, India. In the past few years he have been working in the field of computational chemistry, computational biology, structure-based drug design, bioinformatics, and molecular modeling, to develop pharmaceutical agent to treat various human diseases. He has authored several articles and is a holder of editorial position in several peer reviewed scientific journals.

Structure-Based Drug Design, Molecular modeling and simulation, Docking, In-silico mutation analysis.